Skip to content

Drug interactions

Daunorubicin + Stiripentol

Severity: Minor

Daunorubicin and Stiripentol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Stiripentol inhibits P-glycoprotein and BCRP, transporters involved in anthracycline efflux. Exposure to daunorubicin may increase, potentially worsening myelosuppression and cardiotoxicity.

What this interaction means in plain words

Daunorubicin and Stiripentol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Daunorubicin belongs to Oncology; Stiripentol belongs to Central Nervous System.

Evidence level: Low

Why it happens

Inhibition of P-gp and BCRP efflux transporters by stiripentol may reduce daunorubicin clearance.

What to do

Monitor blood counts and cardiac status. Consider reducing the daunorubicin dose if adverse reactions develop.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Daunorubicin and Stiripentol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Daunorubicin with Stiripentol?

MediHelp rates the interaction as minor. Daunorubicin and Stiripentol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Stiripentol inhibits P-glycoprotein and BCRP, transporters involved in anthracycline efflux. Exposure to daunorubicin may increase, potentially worsening myelosuppression and cardiotoxicity.

How serious is the interaction between Daunorubicin and Stiripentol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac status. Consider reducing the daunorubicin dose if adverse reactions develop.

What other medicines interact with Daunorubicin?

MediHelp also lists interactions of Daunorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclosporine. The full list is on the Daunorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in